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Abstract: The first transition metal catalyzed hydrophosphination of isocyanates is presented. The 
use of low-coordinate iron(II) precatalysts leads to an unprecedented catalytic double insertion of 
isocyanates into the P-H bond of diphenylphosphine to yield phosphinodicarboxamides 
[Ph2PC(=O)N(R)C(=O)N(H)R], a new family of derivatized organophosphorus compounds. This 
remarkable result can be attributed to the low-coordinate nature of the iron(II) centres whose inherent 
electron deficiency enables a Lewis-acid mechanism in which a combination of the steric pocket of 
the metal centre and substrate size determines the reaction products and regioselectivity. 
 
Organophosphorus compounds are a vital class of chemicals with extensive commercial 
applications.[1] Classic synthetic methodologies for phosphine preparation have major drawbacks; 
including poor functional group tolerance, side-product formation, the use of protecting groups and 
stoichiometric amounts of additives, which is a significant disadvantage for atom economy.[2] 
Therefore, there is growing demand to develop atom-economical routes for the preparation of 
functionalized phosphines. In particular, hydrophosphination is an attractive synthetic route to 
phosphine products, proceeding via P-H bond addition across a C-C/X (X = O, N, S) multiple bond.[3] 
However, this reaction can be synthetically challenging as a result of the coordination capability of 
both the phosphine substrates and products which can poison the metal catalyst.  
The hydrophosphination of olefins and alkynes has received wide attention in the last 
decade,[4] but the use of heterocumulene substrates has been less explored, with examples of 
precatalysts for these reactions limited to rare-earth,[5] alkali metal,[6] and group 2 complexes.[7] The 
hydrophosphination of organic isocyanates, yielding phosphinocarboxamide products, is limited to a 
few recent examples, all of which are catalyzed by f-block complexes.[5a-c, 5e] A significant issue with 
the hydrophosphination of isocyanates is that of competing side reactions, such as the 
cyclotrimerization of isocyanates to isocyanurates and catalyst incompatibility towards heteroatom-
containing substrates. This This catalyst incompatibility has been documented for the 
hydrophosphination of aromatic substrates using LY[N(SiMe3)2]2 (L = [4-CH3-2-{(CH3)CH-
[N(CH)2CN]}C6H3]2N).[5c]  
 
 
 
 
 
 
 
Scheme 1. Hydrophosphination of isocyanates with Ph2PH catalyzed by 1 and 2. 
Herein, we report the first transition metal-catalyzed hydrophosphination of isocyanates, 
which affords phosphinodicarboxamides via an unprecedented catalytic double insertion of 
isocyanates into the P–H bond of the phosphine. The reaction between organic isocyanates and 
diphenylphosphine in the presence of catalytic amounts of (2,6-Mes2C6H3)2Fe[8] (1; Mes = 2,4,6-
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Me3C6H2) or (2,6-Tmp2C6H3)2Fe(THF)[9] (2; Tmp = 2,4,5-Me3C6H2) produces the mono- (3) and/or 
diinsertion (4) products, where one or two isocyanate units have inserted into the P-H bond 
respectively (Scheme 1). This result is remarkable since diinsertion processes are incredibly rare.[10] 
Significantly, compounds 4 are a new family of derivatized phosphinodicarboxamides with potential 
applications in coordination chemistry,[11] supramolecular and self-assembled arrays,[12] in 
biomedicine [13] and enantioselective catalysis.[14] 
 
 
Initially, Ph2PH was treated with one equivalent of PhNCO using 5 mol% of 1 as the 
precatalyst (entry 1, Table 1). After 16 hours at room temperature, the solution underwent a colour 
change from yellow to dark red, with concomitant formation of two phosphorous-containing products 
as observed by 1H and 31P{1H}  NMR in a relative ratio of 59:41 (98% conversion). Further analysis 
revealed that the major product was [Ph2PC(=O)N(H)Ph] (3a), while the second product was 
[Ph2C(=O)N(Ph)C(=O)N(H)Ph] (4a), resulting from the double insertion of two isocyanate molecules 
into the P H bond of Ph2PH. In order to optimise the formation of 4a the ratio of PhNCO:Ph2PH was 
changed from 1:1 to 2:1 (entry 2, Table 1), resulting in an increase in the ratio of 4a (67%) with 
respect to 3a (33%). Three-coordinate complex 2 shows a higher activity than 1; high conversion is 
achieved in a significantly shorter time with a similar product distribution (entry 3, Table 1). Very 
similar behaviour is observed for pTolNCO (entries 4 and 5, Table 1). When 3,5-(OMe)2C6H3NCO is 
Table 1. Catalytic hydrophosphination of isocyanates mediated by 1 and 2.[a] 
Entr
y 
RNCO Cat.  RNCO: 
Ph2PH 
t (h) Conv. (%)[b] 3/4/5 (%)[c] 
1 Ph 1 1:1 16 98 59/41/0 
2 Ph 1 2:1 15 95 33/67/0 
3 Ph 2 2:1 6 96 35/65/0 
4 pTol 1 2:1 16.5 95 27/72/1 
5 pTol 2 2:1 4.8 94 36/63/1 
6 (OMe)2C6H3 1 2:1 12 95 43/57/0 
7 (OMe)2 C6H3 2 2:1 3 99 46/54/0 
8 4-BrC6H4 1 2:1 15 99 30/70/0 
9 4-BrC6H4 2 2:1 4 99 27/71/2 
10 nHx 1 1:1 15 99 13/26/5/56[d] 
11 nHx 1 2:1 15 99 8/39/3/49[d] 
12 nHx 2 2:1 15 99 12/36/7/46[d] 
13 Cy 1 1:1 16 90 93/0/6[e] 
14 Cy 2 1:1 8 89 95/0/5 
15 iPr 1 1:1 16 55 91/5/4 
16 iPr 1[f] 1:1 1.6 89 96/0/4 
17 iPr 2[f] 1:1 1 92 97/0/3 
18 tBu 1[f] 1:1 16 70 91/0/9 
19 tBu 2[f] 1:1 16 77 86/0/14 
[a] Reaction conditions: 10 mg cat. (5 mol%), 0.6 mL of C6D6, 25 °C. [b] Determined by 1H 
NMR and 31P{1H} NMR spectroscopy. [c] Ratio by 1H NMR and 31P{1H} NMR. [d] 
Cyclotrimer ratio. [e] 1% unidentified 31P{1H} peak. [f] Catalysis performed at 60 °C. 
3 
 
used the hydrophosphination proceeds with a higher reaction rate and a small decrease in the 
amount of the diinsertion product (entries 6 and 7, Table 1). Reactions with isocyanates featuring 
functional groups proceed in a similar manner, with excellent conversions for substrates which bear 
either electron donating or withdrawing groups (entries 6-9, Table 1). 
To explore the scope of the reaction aliphatic isocyanates were tested. When the reaction 
was performed with nHxNCO, the hydrophosphination competes with the cyclotrimerization reaction 
leading to a mixture of [nHxNCO]3,[9] [Ph2PC(=O)N(H)
nHx] (3e) and 
[Ph2PC(=O)N(
nHx)C(=O)N(H)nHx] (4e) (entries 10-12, Table 1). Meanwhile, reactions with more 
sterically encumbered secondary and tertiary isocyanates (CyNCO, iPrNCO and tBuNCO) afforded 
almost exclusively the monoinsertion products (3f-h, entries 13-19, Table 1). For iPrNCO and 
tBuNCO the temperature was raised to 60 °C in order to reach reasonable conversions in 16 h 
(entries 15-19, Table 1) viz. ca. 90% for 3g and >70% for 3h; previous attempts by others to catalyze 
the hydrophosphination of tBuNCO with Ph2PH were low yielding (<20%).[5e] Collectively, these 
results indicate that the observed selectivity between the catalysis of the mono- and diinsertion of 
isocyanates into Ph2PH may be governed by steric factors obtaining preferentially the diinsertion 
product for less bulky isocyanates and the monoinsertion product for secondary and tertiary aliphatic 
isocyanates.  
Changing the solvent from C6D6 to THF resulted in a significant change in the selectivity 
(Table S1 and Scheme 2); affording the monoinsertion product almost exclusively. A decrease in 
catalyst activity was also observed, and the reactions required heating to 60 °C to obtain moderate 
conversions (entries 1-4, Table S1). 
 
 
 
 
Scheme 2. Hydrophosphination products obtained when using THF (left) or NEt3·HCl in C6D6 (right) 
catalyzed with 5 mol% of 1. 
 
To investigate the faster rates for precatalyst 2 compared to 1 the hydrophosphination 
catalysis was monitored using 1H and 31P{1H} NMR spectroscopy. When using 1, an induction period 
of around 2 h was observed (Figure 1, and ESI), indicating that the two-coordinate complex 1 is not 
the true catalyst and that a transformation takes place before the catalysis begins. No induction 
period is observed for 2, where the catalysis starts immediately after substrate addition. It is likely 
that the same initial reaction takes place for 2 but the labile THF ligand is easily displaced making 
this step considerably faster. Surprisingly, when complex 1 was reacted separately with either Ph2PH 
or CyNCO no reaction was observed after 48 h at room temperature by NMR and IR spectroscopy. 
As soon as the other substrate is added the formation of product 3f is observed. Stoichiometric 
studies were not conclusive as IR spectroscopy shows several peaks in the amide region, but 
indicates that the active catalyst is an iron amidate complex (Scheme 3, A). The formation of this 
species could be an equilibrium; therefore both Ph2PH and CyNCO are needed to drive the reaction 
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to A. However, the possibility that both substrates are required for precatalyst activation cannot be 
ruled out. 
Figure 1. Conversion (%) vs. time (h) for the hydrophosphination of CyNCO with 5 mol% cat. of 1 
(+) and 2 (○) in C6D6 at 25 °C. 
 
Sigmoidal reaction kinetics have been used as evidence for a heterogeneous mechanism 
where the catalyst may be bulk iron metal or trace iron nanoclusters.[15] In order to distinguish the 
true nature of the catalyst, poisoning Fe with Hg and CS2 were performed (see ESI). No change was 
observed in either the reaction rate or catalyst selectivity suggesting that the reaction most likely 
occurs through a homogenous mechanism. Moreover, the reaction does not appear to be radical 
catalyzed since the presence of excess cumene does not affect the rate of the reaction (see ESI).[16] 
No significant changes were observed when triethylamine was added to the reaction mixture (entry 
1, Table S2). The addition of a weak acid (NEt3·HCl) favours the double insertion product affording 
4a and 4c almost exclusively (entries 2 and 4, Table S2 and Scheme 2), highlighting the mechanistic 
differences between our catalytic system and traditional palladium catalysts.[17]  
With these mechanistic considerations in mind the proposed catalytic cycle is shown in 
Scheme 3. Due to the relatively high oxidation state of the iron(II) and its coordinative unsaturation 
it is conceivable to envisage the metal centre acting as a Lewis acid.[4e, 18] Therefore, a likely first 
step is the coordination of an isocyanate molecule leading to intermediate B. Nucleophilic attack of 
free Ph2PH on the coordinated isocyanate leads to P-C bond formation and the transient species C. 
Similar substrate coordination followed by outer-sphere attack of a phosphine have been 
proposed.[4e, 19] A 1,3-proton shift, followed by addition of a new molecule of isocyanate regenerates 
the active species B with displacement of 3. When the phosphinocarboxamide (3) produced in cycle 
1 contains a smaller R group it is also possible to proceed into cycle 2 via a nucleophilic attack on B 
with the subsequent formation of D. Proton transfer followed by displacement of the 
phosphinodicarboxamide (4) by an incoming isocyanate molecule results in the regeneration of B. 
When coordinating solvents such as THF are used, solvation of intermediate B can occur blocking 
the income of a phosphinocarboxamide molecule enforcing the monoinsertion pathway. The weak 
acid will likely aid the protonolysis step in cycle 2; a rate limiting step for hydroamination reactions.[20]  
Indeed, when a mixture of PhNCO and CyNCO are reacted with diphenylphosphine (1:1:1) a 
combination of four products 3a/3f/4a/4i are obtained (Scheme S1, ESI). The diinsertion product 4i 
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[Ph2PC(=O)N(Ph)C(=O)NH(Cy)] results from the coordination of CyNCO with nucleophilic attack of 
[Ph2PC(=O)N(H)Ph] (3a) which is in agreement with our proposed mechanism. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Proposed mechanism for the mono- and diinsertion of isocyanates into the P-H bond of 
Ph2PH. 
 
An alternate mechanism similar to those reported for rare-earth precatalysts[5a,b,e] where the 
Ph2PH attacks the metal centre first through protolytic cleavage of the amide ligand has been 
dismissed due to the lack of evidence of the formation of (2,6-MesC6H3)C(=O)NH(R) via 1H NMR or 
IR spectroscopy. 
Reactions were scaled up successfully obtaining good isolated yields for the diinsertion 
products (4a-d) and for monoinsertion products (3a,c-d,f-h) (see ESI for full procedures). 
In summary, the catalytic hydrophosphination of isocyanates under mild conditions has been 
demonstrated using iron precatalysts 1 and 2, which display remarkable reactivity due to their low 
coordination number and the unique steric pocket created by the bulky m-terphenyl ligands. Simple 
modification of the reaction conditions can control the synthetic outcome yielding either mono- or 
diinsertion products with high selectivity.  
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Supplementary Information 
General Procedures  
All compounds prepared herein are air and moisture sensitive; therefore, all reactions and 
manipulations were performed by using standard Schlenk line and glovebox equipment 
under an atmosphere of purified argon or nitrogen. Iso-hexane (contains <5% n-hexane) 
and n-pentane were dried by passing through a column of activated 4 Å molecular sieves. 
THF and toluene were freshly distilled over sodium benzophenone ketyl (THF) or molten 
potassium (toluene) under nitrogen. All solvents were degassed in vacuo and stored over a 
potassium mirror (iso-hexane, n-pentane, toluene) or activated 4 Å molecular sieves (THF) 
prior to use. Benzene-d6 was dried over potassium, and THF-d8 was dried over CaH2. Both 
were degassed with three freeze/pump/thaw cycles prior to use. NMR spectroscopy were 
performed on either a Bruker DPX400, AV400, AV(III)400, AV(III)400HD, AV(III)500, 
AV(III)600 or AV(III)800 spectrometers. Chemical shifts are quoted in ppm relative to neat 
TMS (1H, 13C{1H}), LiCl/D2O solution (7Li{1H}), H3PO4 (31P{1H}), MeNO2 (15N). Selected 15N 
NMR resonances were obtained from 1H, 15N HSQC. [2,6-Tmp2C6H3Li]2,1 (2,6-
Tmp2C6H3)2Fe(THF)1 and (2,6-Mes2C6H3)2Fe2 were prepared following the procedures 
described in the literature. Mass spectra were measured by the departmental service at the 
University of Nottingham. IR absorption spectroscopy were recorded on a Bruker Alpha 
FTIR instrument with a ‘Platinum’ ATR attachment. Elemental microanalysis was performed 
by Mr Stephen Boyer at the Microanalysis Service, London Metropolitan University, UK. All 
the isocyanates are commercially available and were transferred directly into the glovebox 
after which 4 Å molecular sieves were added with the exception of 3,5-dimethoxyphenyl 
isocyanate which was dried overnight under vacuum. Diphenylphosphine (Sigma-Aldrich) 
was supplied in a Sure/Seal™ bottle and was transferred directly into the glove box. 
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Table S1. Catalytic hydrophosphination of isocyanates mediated by complex 1 in THF.[a]  
Entry RNCO 
RNCO: 
Ph2PH 
T (ºC) t(h) Cat. Conv. (%)[b] 
3/4/5 
(%)[c] 
1 Ph 1:1 25 16 1 40 97/0/3 
2 Ph 1:1 60 32 1 80 100/0/0 
3 (OMe)2C6H3 1:1 60 32 1 66 99/1/0 
4 4-BrC6H4 1:1 60 24 1 50 98/0/2 
[a] Reaction conditions: 0.6 mL of THF, 5 mol% cat. [b] Determined by 31P{1H} NMR 
spectroscopy. [c] Ratio determined by 31P{1H} NMR. 
 
 
Table S2. Catalytic hydrophosphination of isocyanates mediated by complex 1 with 
additives.[a]  
Entry RNCO 
RNCO: 
Ph2PH 
t(h) Additive Cat. 
Conv. 
(%)[b] 
3/4/5 
(%)[c] 
1 3,5-(OMe)2 
C6H3 
2:1 16 NEt3 1 >99 37/63/0 
2 3,5-(OMe)2 
C6H3 
2:1 16 NEt3·HCl[d] 1 >99 3/97/0 
3 3,5-(OMe)2 
C6H3 
2:1 16 NEt3·HCl[d] - [e] 19 94/0/1[f] 
4 Ph 2:1 16 NEt3·HCl[d] 1 >99 1/99/0 
5 Cy 1:1 48 NEt3·HCl[d] 1 0 - 
[a] Reaction conditions: 25 ºC, 0.6 mL of C6D6, 5 mol% cat. [b] Determined by 1H NMR 
and 31P{1H} NMR spectroscopy. [c] Ratio determined by 1H NMR and 31P{1H} NMR. [d] 
0.5 eq. wrt Ph2PH; several drops of THF-d8 are added to solubilise NEt3·HCl. [e] Reactions 
performed without catalyst. [f] 5% unidentified 31P{1H} NMR peak. 
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Table S3. Selected Data for 3a, c-h and 4a-e,i.  
 Isolated 
Yield (%) 
31P 
(ppm) 
13CPCO 
(ppm) 
1J(C,P) 
(Hz) 
1HNH 
(ppm) 
15NNH 
(ppm) 
νPCO 
(cm-1) 
 νNCONH 
(cm-1) 
3a 71 ‒0.2 175.2 15 7.24 - 1688[a] - 
3c 57 0.8 175.5 16 7.37 - 1630 - 
3d 64 0.2 175.4 16[a] 7.00 - 1630[a] - 
3f 56 ‒4.3 174.9 12 5.44 111.2 1645 - 
3g 57 ‒4.0 175.0 13 5.35 113.5 1641 - 
3h 67 ‒2.7 175.3 13 5.42 117.6 1632 - 
4a 50 8.3 184.9 29 11.57 116.7 1718 1588 
4b 55 8.0 184.9 28 11.58 - 1716 1536 
4c 65 7.7 184.9 30 11.74 - 1719 1544 
4d 79 8.8 185.0 31 11.41 - 1717 1594 
4e - 8.4 182.8 25 9.22 - - - 
4i - 7.8 183.6 27 9.22 - - - 
[a] values from reference 3 
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General Procedures for the Catalytic Hydrophosphination of Isocyanates 
 
Standard procedure for the catalytic hydrophosphination of isocyanates: In a Young’s 
NMR tube 5 mol% of the precatalyst (1: 10.0 mg, 0.0147 mmol; 2: 10.0 mg, 0.0132 mmol) 
was dissolved in C6D6 (0.6 mL) in a glove-box with the corresponding isocyanate and Ph2PH 
(1:1 or 2:1 of RNCO:Ph2PH). The reaction was either carried out at room temperature and 
monitored by 1H and 31P{1H} NMR spectroscopy or heated to 60 °C; the samples were 
maintained at 60 °C for 16 h and 1H and 31P{1H} NMR spectroscopy were performed at the 
final time. Conversion was quantified by integration of 1H and 31P{1H} NMR spectra.  
 
Standard procedure for in situ NMR reaction monitoring for the catalytic 
hydrophosphination of isocyanates: In a Young’s NMR tube 5 mol% of precatalyst (1: 
10.0 mg, 0.0147 mmol; 2: 10.0 mg, 0.0132 mmol) was dissolved in C6D6 (0.6 mL) with the 
corresponding isocyanate. The solution was cooled to ‒30 °C after which Ph2PH (1:1 or 2:1 
of RNCO:Ph2PH) was added and the sample cooled to ‒78 °C to prevent the reaction from 
initiating. The sample was then transferred to the NMR spectrometer and monitored directly 
at 25 °C or heated to 60 °C. Conversion was quantified by integration of 1H and 31P{1H} NMR 
spectra. 
 
Standard procedure for the catalytic hydrophosphination of isocyanates in THF: In a 
Young’s NMR tube 5 mol% of the precatalyst (1: 10.0 mg, 0.0147 mmol) was dissolved in 
THF (0.6 mL) in a glove-box with the corresponding isocyanate (0.293 mmol), Ph2PH (51 
µL, 0.293 mmol) and a C6D6 insert. The reaction was either carried out at room temperature 
or heated to 60 °C and monitored by 31P{1H} NMR spectroscopy. Conversion was quantified 
by integration of the 31P{1H} NMR spectrum. 
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Catalytic hydrophosphination of Isocyanates with Additives 
In situ NMR reaction monitoring for the catalytic hydrophosphination of isocyanates 
with additives: In a Young’s NMR tube 5 mol% of the precatalyst 1 (10.0 mg, 0.0147 mmol) 
was dissolved in C6D6 (0.6 mL) with CyNCO (38 µL, 0.294 mmol) and the corresponding 
additive (see Table S4 below). The solution was cooled to ‒30 °C after which Ph2PH (51 µL, 
0.294 mmol) was added and the sample cooled to ‒78 °C to prevent the reaction from 
initiating. The sample was then transferred to the NMR spectrometer and monitored directly 
at 25 °C. Conversion was quantified by integration of 1H and 31P{1H} NMR spectra.  
 
Table S4. Additives and quantities used in the in situ NMR reaction monitoring 
experiments. 
Additive  
CS2 (0.05 M in toluene) 29 µL, 0.00147 mmol 
Hg (l) ca. 1 drop 
Cumene 10 µL, 0.0735 mmol 
 
 
Catalytic hydrophosphination of isocyanates with weak base/acid: In a Young’s NMR 
tube 5 mol% of the precatalyst 1 (10.0 mg, 0.0147 mmol), the corresponding isocyanate, 
Ph2PH (51 µL, 0.294 mmol) and the additive (see Table S5 below) were dissolved in C6D6 
(0.6 mL) in a glove-box. The reactions were kept at room temperature and monitored by 1H 
and 31P{1H} NMR at the final time. Conversion was quantified by integration of 1H and 31P{1H} 
NMR spectra.  
 
Table S5.  Additives and isocyanate quantities used in the catalytic hydrophosphination 
of isocyanates with a weak base (NEt3) or weak acid (Et3N·HCl). 
Additive RNCO Solvent Time 
NEt3  (41 µL, 
0.294 mmol) 
3,5-(OMe)2 C6H3 
(105 mg, 
0.588 mmol) 
C6D6 (0.6 mL) 16 h 
Et3N·HCl  (40.4 
mg, 0.294 mmol) 
3,5-(OMe)2 C6H3 
(105 mg, 
0.588 mmol) 
C6D6 (0.6 mL), 
THF-d8 (ca. 2 drops) 
16 h 
Ph 
(64 µL, 
0.588 mmol) 
C6D6 (0.6 mL), 
THF-d8 (ca. 2 drops) 
16 h 
Cy 
(75 µL, 
0.588 mmol) 
C6D6 (0.6 mL), 
THF-d8 (ca. 2 drops) 
48 h 
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Catalytic hydrophosphination of Isocyanates with Mixed Isocyanates 
 
Hydrophosphination with PhNCO and CyNCO:  
 
Scheme S1. Hydrophosphination of mixture of phenyl and cyclohexyl isocyanate with 
diphenylphosphine (1:1:1) using 1. A combination of 4 products are obtained 3a/3f/4a/4i.  
 
Experimental procedure: In a Young’s NMR tube 5 mol% of the precatalyst (1: 10.0 mg, 
0.0147 mmol) was dissolved in C6D6 (0.6 mL) in a glove-box with Ph2PH (51 µL, 0.293 
mmol), PhNCO (32 µL, 0.293 mmol) and CyNCO (37 µL, 0.293 mmol). The reaction was 
carried out at room temperature and monitored by 1H and 31P{1H} NMR spectroscopy. After 
16 h at room temperature catalysis was complete (>99% conversion) and the formation of 
3a, 3f, 4a and 4i were observed by NMR with a ratio of 26:27:30:17 (3a:3f:4a:4i). Selected 
spectroscopic data for phosphacarboxamide 4i: 1H NMR (400 MHz, C6D6, 25 ºC) δ = 9.22 
(s, 1H, NH), 7.63–6.82 (Ar), 3.93 (CH2), 1.97–1.87 (m, CH2), 1.49–1.45 (m, CH2), 1.18 (m, 
CH2), 1.11–1.04 (m, CH2). 31P{1H} NMR (162 MHz, C6D6, 25 ºC) δ = 7.8 (s, 1P, Ph2P). MS 
(ESI) Expected: 431.1883, found: 431.1883 [M+H]+ (err [ppm] = 0.1). 
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Procedures for the Scaled-up Catalytic Hydrophosphination of 
Isocyanates 
 
3a, c and d: In a Schlenk flask 5 mol% of 1 (30.0 mg, 0.0441 mmol), Ph2PH (153 µL, 0.880 
mmol) and the isocyanate (0.880 mmol) were dissolved in THF (1.5 mL) and stirred at 60 
°C for 3 days (3a and 3c) or 2 days (3d). The solvent was removed in vacuo and the solid 
was washed with cold iso-hexane (3 × 5 mL) and dried under vacuum resulting in the 
isolation of the corresponding pure phosphinocarboxamide as a white powder (3a:  190 mg, 
71%; 3c: 184 mg, 57%; 3d: 217 mg, 64%). 
 
3f-h: In a Schlenk flask 5 mol% of 1 (30.0 mg, 0.0441 mmol), Ph2PH (153 µL, 0.880 mmol) 
and the isocyanate (0.880 mmol) were dissolved in toluene (5 mL) and stirred at room 
temperature (Cy) or at 60 °C (iPr, tBu) for 16 h. The solvent was removed in vacuo and the 
oily residue was extracted into n-pentane (2 × 10 mL) and stored at ‒30 °C for one day. This 
resulted in the precipitation of while crystalline solid of the corresponding pure 
phosphinocarboxamide (3f: 153 mg, 56%; 3g: 137 mg, 57%; 3h: 168 mg, 67%). 
 
4a-d: In a Schlenk flask 5 mol% of 1 (30.0 mg, 0.0441 mmol), Ph2PH (153 µL, 0.880 mmol) 
and the isocyanate (1.76 mmol) were dissolved in toluene (5 mL) and stirred at room 
temperature for 16 h. The solvent was removed in vacuo and the oily residue was washed 
with n-pentane (2 × 10 mL) and dried for ca. 6 h enabling the isolation of the a while solid of 
the corresponding phosphinocarboxamide (4a: 186 mg, 50%; 4b: 220 mg, 55%; 4c: 304 mg, 
65%, 4d: 406 mg, 79%). 
 
Large Scale-up: In a Schlenk flask 5 mol% of 1 (102 mg, 0.150 mmol), Ph2PH (522 µL, 
3.00 mmol), PhNCO (653 µL, 6.00 mmol) and Et3N·HCl (404 mg, 2.93 mmol) were dissolved 
in toluene (6 mL) and stirred at room temperature for 16 h. The solvent was removed in 
vacuo and the product was extracted into toluene (20 mL) and the solvent removed yielding 
a white solid which was dried for ca. 3 h. The solid was washed with iso-hexane (3 × 10 mL) 
and dried for ca. 6 h enabling the isolation of the a while solid of the corresponding 
phosphinocarboxamide (4a: 936 mg, 74%). 
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Spectroscopic Data 
Ph2PC(=O)NH(Ph) (3a). 
White solid: 190 mg, 71%.1H NMR (400 MHz, C6D6, 25 ºC ) δ 7.64–7.52 
(m, 4H, PPh2o), 7.35 (d, 3J(H,H) = 8.0 Hz, 2H, Pho), 7.24 (d, 3J(H,P) = 7.6 
Hz, 1H, NH), 7.07–7.01 (m, 6H, PPh2m+p), 6.98 (t, 3J(H,H) = 7.9 Hz, 2H, 
Phm), 6.82 (t, 3J(H,H) = 7.4 Hz, 1H, Php). 13C{1H} NMR (101 MHz, C6D6, 25 ºC) δ = 175.2 (d, 
1J(C,P) = 15 Hz, C=O), 138.5 (Phi), 134.8 (d, 2J(C,P) =19 Hz, PPh2o), 134.3 (d, 1J(C,P) = 10 
Hz, PPh2i), 129.9 (PPh2m), 129.3 (Phm), 129.2 (PPh2p), 124.6 (Php), 119.4 (Pho). 31P{1H} (162 
MHz, C6D6, 25 ºC) δ ‒0.2 (s, 1P, Ph2P). MS (ESI) Expected: 306.1039, found: 306.1042 (err 
[ppm] = 1.00) [M+H]+ (100%). Spectroscopic data matched previous reported literature.3 
 
Ph2PC(=O)NH[3,5-(OMe)2C6H3] (3c). 
White solid: 184 mg, 57%.1H NMR (400 MHz, C6D6, 25 ºC ) δ = 7.57 
(td, 3J(H,H) = 6.9, 3J(H,P) = 6.9, 4J(H,H) = 2.9 Hz, 4H, PPh2o), 7.37 
(s, 1H, NH), 7.18–6.94 (m, 6H, PPh2m+p), 6.91–6.75 (m, 2H, Pho), 
6.34 (s, 1H, Php), 3.27 (s, 6H, OCH3). 13C{1H} NMR (101 MHz, 
C6D6, 25 ºC) δ 175.5 (d, 1J(C,P) = 16 Hz, C=O), 161.8 (Phm), 140.4 (d, 3J(C,P) = 5 Hz, Phi), 
134.7 (d, 1J(C,P) = 19 Hz, PPhi,), 134.2 (d, 2J(C,P) = 11 Hz, PPh2o), 129.9 (PPh2p), 129.2 
(d, 3J(C,P) = 7 Hz, PPh2m), 97.9 (Pho), 97.6 (Php), 55.0 (OCH3). 31P{1H} (162 MHz, C6D6, 25 
ºC) δ 0.8 (s, 1P, Ph2P). MS (ESI) Expected: 366.1257, found: 366.1254 (err [ppm] = 1.00) 
[M+H]+ (100%). IR (ATR) ν/cm-1 = 3278 (N-H), 1630 (C=O). 
 
Ph2PC(=O)NH(4-BrC6H4) (3d). 
White solid: 217 mg, 64%.1H NMR (400 MHz, C6D6, 25 ºC) δ 7.62–
7.45 (m, 4H, PPh2o), 7.09–7.01 (m, 9H, NH, PPh2m+p, Pho), 6.96 (d, 
3J(H,H) = 8.6 Hz, 2H, Phm). 13C{1H} NMR (151 MHz, C6D6, 25 ºC) δ 
175.4 (d, 1J(C,P) = 16 Hz, C=O), 137.3 (Phi), 134.8 (d, 2J(C,P) = 19 Hz, PPh2o), 134.0 (d, 
1J(C,P)  = 10 Hz, PPhi), 132.1 (Pho), 130.0 (PPhp), 129.2 (d, 3J(C,P)  = 5 Hz PPhm), 121.1 
(Phm), 117.1 (Php). 31P{1H} (162 MHz, C6D6, 25 ºC) δ 0.2 (s, 1P, Ph2P). MS (ESI) Expected: 
405.9967, found: 405.9966 (err [ppm] = 0.10) [M+Na]+ (100%). Spectroscopic data matched 
previous reported literature.3 
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Ph2PC(=O)NH(Cy) (3f). 
White solid: 153 mg, 56%. 1H NMR (800 MHz, C6D6, 25 ºC) δ 7.67 (td, 
3J(H,H) = 7.4 Hz, 3J(H,P) = 7.4 Hz, 4J(H,H) = 1.4 Hz, 4H, PPh2o), 7.12–
7.02 (m, 6H PPh2m+p), 5.44 (br d, 3J(H,P) = 4.1 Hz, 1H, NH), 3.95 (dddd, 
J = 14.2, 10.2, 7.8, 3.9 Hz, 1H, CHa), 1.63 (dt, 2J(H,H) = 12.9 Hz, 3J(H,H) 
= 4.3 Hz, 2H, CHb’), 1.27 (dt, 2J(H,H) = 13.7, 2J(H,H) = 4.2 Hz, 2H, CHc’), 1.23 (dt, 2J(H,H) = 
12.8 Hz, 2J(H,H) = 4.2 Hz, 1H, CHd’), 1.07–0.98 (m, 2H, CHc’’), 0.79 (ddt, 2J(H,H) = 11.6 Hz, 
2J(H,H) = 11.6 Hz, 3.6, 1H, CHd’’), 0.74–0.65 (m, 2H, CHb’’). 13C{1H} NMR (101 MHz, C6D6, 
25 ºC) δ 174.9 (d, 1J(C,P) = 12 Hz, CO), 135.4 (d, 1J(C,P) = 12 Hz, PPh2i), 134.7 (d, 2J(C,P) 
= 19 Hz, PPh2o), 129.6 (PPh2p), 129.0 (d, 3J(C,P) = 6.6 Hz, PPh2m), 48.7 (CH), 32.8 (CbH2), 
25.6 (CdH2), 24.7 (CcH2). 31P{1H} (162 MHz, C6D6, 25 ºC) δ ‒4.3 (s, 1P, Ph2P). 15N NMR (81 
MHz, C6D6, 25 ºC) δ 111.2 (1N, NH). MS (ESI) Expected: 312.1512, found: 312.1526 (err 
[ppm] = 4.60) [M+H]+ (100%). Elemental analysis C19H22NOP: calcd. C 73.29, H 7.12, N 
4.50; found: C 73.16, H 7.00, N 4.58 %. IR (ATR) ν/cm-1 = 3244 (N-H), 1645 (C=O). 
Spectroscopic data matched previous reported literature.3 
 
Ph2PC(=O)NH(iPr) (3g). 
White crystalline solid: 137 mg, 57%. 1H NMR (800 MHz, C6D6, 25 ºC ) δ 
7.64 (ddd, 3J(H,H) = 7.5 Hz, 3J(H,P) = 7.5 Hz, 4J(H,P) = 1.5 Hz, 4H 
PPh2o), 7.07 (t, 3J(H,H) = 7.4 Hz, 4H PPh2m), 7.06–7.03 (m, 2H, PPh2p), 
5.35 (s, 1H, NH), 4.14 (oct, 3J(H,H) = 6.8 Hz, 1H, CH), 0.72 (d, 3J(H,H) = 6.6 Hz, 6H, CH3). 
13C{1H} (101 MHz, C6D6, 25 ºC) δ 175.0 (d, 1J(C,P) = 13 Hz, CO), 135.2 (d, 1J(C,P) = 12 Hz, 
PPh2i), 134.6 (d, 2J(C,P)  = 19 Hz, PPh2o), 129.6 (s, PPh2p), 129.0 (d, 3J(C,P) = 7 Hz, PPh2m), 
42.1 (CH), 22.3 (CH3). 31P{1H} (162 MHz, C6D6, 25 ºC) δ ‒4.0 (s, 1P, Ph2P). 15N NMR (81 
MHz, C6D6, 25 ºC) δ 113.5 (1N, NH). MS (ESI) Expected: 272.1199, found: 272.1205 (err 
[ppm] = 2.40) [M+H]+ (62.1 %). IR (ATR) ν/cm-1 = 3258 (N-H), 1641 (C=O). 
 
Ph2PC(=O)NH(tBu) (3h). 
White crystalline solid: 168 mg, 67%. 1H NMR (800 MHz, C6D6, 25 ºC ) δ 
7.64 (ddd, 3J(H,H) = 7.5 Hz, 3J(H,P) = 7.5 Hz, 3J(H,P) = 1.7 Hz, 4H, 
PPh2o), 7.07 (t, 3J(H,H) = 7.4 Hz, 4H PPh2m), 7.05–7.02 (m, 2H, PPh2p), 
5.42 (s, 1H, NH), 1.12 (s, 9H, CH3). 13C{1H} (101 MHz, C6D6, 25 ºC) δ 175.3 (d, 1J(C,P) = 
13 Hz, CO), 135.6 (d, 1J(C,P) = 12 Hz, PPh2i), 134.6 (d, 2J(C,P) = 19 Hz, PPh2o), 129.5 (s, 
PPh2p), 129.0 (d, 3J(C,P) = 7 Hz, PPh2m), 52.5 (d, 3J(C,P) =  3 Hz, (C(CH3)3), 28.6 (CH3). 
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31P{1H} (162 MHz, C6D6, 25 ºC) δ ‒2.7 (s, 1P, Ph2P). 15N NMR (81 MHz, C6D6, 25 ºC) δ 
117.6 (1N, NH). MS (ESI) Expected: 286.1355, found: 286.1372 (err [ppm] = 5.90) [M+H]+ 
(72.2 %). Elemental analysis C17H20NOP: calcd. C 71.56, H 7.07, N 4.91; found: C 71.63 H 
6.93, N 5.01 %. IR (ATR) ν/cm-1 = 3310 (N-H), 1632 (C=O).  
 
Ph2PC(=O)N(Ph)C(=O)NH(Ph) (4a).  
White solid: 186 mg, 50%. 1H NMR (800 MHz, C6D6, 25 ºC) δ = 11.57 (s, 1H, NH), 7.67 (d, 
3J(H,P) = 7.9 Hz, 2H, PhBo), 7.31 (t, 3J(H,P) = 7.8 Hz, 3J(H,H) = 7.8 
Hz, 4H, PPho), 7.13–6.97 (m, 8H, PPh2m+p + PhBm), 6.92 (t, 3J(H,H) = 
7.3 Hz, 1H, PhAp), 6.87–6.82 (m, 3H, PhBp + PhAm), 6.80 (d, 3J(H,H) 
= 7.9 Hz, 2H, PhAo). 13C{1H} (101 MHz, C6D6, 25 ºC) δ 184.9 (d, 
1J(C,P) = 29 Hz, PC=O), 151.2 (C=O), 138.7 (PhBi), 136.5 (d, 3J(C,P) = 4 Hz, PhAi), 135.1 
(d, 2J(C,P) = 21 Hz, PPh2o), 133.3 (d, 1J(C,P) = 8 Hz, PPh2i), 132.3 (d, 4J(C,P) = 4 Hz, PhAo), 
129.9 (PPh2p), 129.4 (PhBm), 129.2 (PhAp), 128.8 (PPh2m), 128.7 (PhAm), 124.2 (PhBp), 120.1 
(PhBo). 31P{1H} (162 MHz, C6D6, 25 ºC) 8.3 (s, 1P, Ph2P). 15N NMR (81 MHz, C6D6, 25 ºC) δ 
116.7 (1N, NH). MS (ESI) Expected: 425.1413, found: 425.1414 (err [ppm] = 0.10) [M+H]+ 
(30.6 %). IR (ATR) ν/cm-1 = 3259 (N-H), 1718 (PC=O), 1588 (C=O). 
 
Ph2PC(=O)N(pTol)C(=O)NH(pTol) (4b). 
White solid: 220 mg, 55%. 1H NMR (400 MHz, C6D6, 25 ºC ) δ 
11.58 (s, 1H, NH), 7.63 (d, 3J(H,H) = 8.2 Hz, 2H, PhBo), 7.35 (td, 
3J(H,H) =  8.1, 3J(H,P) = 8.1, 4J(H,H) =1.6 Hz, 4H, PPh2o), 7.06–
6.98 (m, 6H, PPh2m+p), 6.88 (d, 3J(H,H) = 8.2 Hz, 2H, PhBm), 6.73 
(dd,3J(H,H) = 8.1 Hz, 5J(H,P) = 1.5 Hz, 2H, PhAo), 6.67 (d, 3J(H,H) 
= 8.1 Hz, 2H, PhAm), 2.02 (s, 3H, CH3B), 1.97 (s, 3H, CH3A). 13C{1H} (101 MHz, C6D6, 25 ºC) 
δ 184.9 (d, 1J(C,P) = 28 Hz, PC=O), 151.3 (C=O), 138.8 (PhAp), 136.3 (PhBp), 135.1 (d, 
2J(C,P) = 21 Hz, PPh2o), 134.0 (PhAi), 133.6 (d, 1J(C,P) = 8 Hz, PPh2i), 133.4 (PhBi), 132.1 
(d, 4J(C,P) = 3 Hz, PhAo), 130.0 (PhBm), 129.2 (PPh2p), 129.1 (PhAo), 128.7 (d, 3J(C,P) = 8 
Hz, PPh2m), 120.2 (PhBo), 21.1 (CH3A), 20.8 (CH3B). 31P{1H} (162 MHz, C6D6, 25 ºC) δ 8.0 
(s, 1P, Ph2P). MS (ESI) Expected: 453.1726, found: 453.1731(err [ppm] = 1.10 [M+H]+ (100 
%). Elemental analysis C28H25N2O2P: calcd. C 74.32, H 5.57, N 6.19; found: C 74.01, H 
5.39, N 6.07 %. IR (ATR) ν/cm-1 = 3202 (N-H), 1716 (PC=O), 1536 (C=O). 
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Ph2PC(=O)N(3,5-(OMe)2C6H3)C(=O)NH(3,5-(OMe)2C6H3) (4c). 
White solid: 304 mg, 65%.1H NMR (400 MHz, C6D6, 25 ºC ) δ 
11.74 (s, 1H, NH), 7.43–7.34 (m, 4H, PPh2o), 7.22 (d, 4J(H,H) = 
2.3 Hz, 2H, PhBo), 7.06–6.96 (m, 6H, PPh2m+p), 6.53 (t, 4J(H,H) 
= 2.3 Hz, 1H, PhAp), 6.42 (t, 4J(H,H) = 2.3 Hz, 1H, PhBp), 6.19 
(dd, 4J(H,H) = 2.3 Hz, 5J(H,P) = 1.3 Hz, 2H, PhAo), 3.30 (s, 6H, 
OCH3B), 3.09 (s, 6H, OCH3A). 13C{1H} (101 MHz, C6D6, 25 ºC) δ = 184.9 (d, 1J(C,P)  = 30 
Hz, PC=O), 162.0 (PhBm), 160.9 (PhAm), 151.1 (C=O), 140.5 (PhBi), 138.2 (d, 3J(C,P) = 4 Hz, 
PhAi), 135.1 (d, 2J(C,P) = 21 Hz, PPh2o),133.8 (d, 1J(C,P) = 9 Hz, PPh2i), 129.8 (PPh2p), 
128.8 (d, 3J(C,P) = 8 Hz, PPh2m), 110.4 (d, 4J(C,P) = 4 Hz, PhAo), 102.8 (PhAp), 98.4 (PhBo), 
97.8 (PhBp), 54.9 (OCH3B), 54.9 (OCH3A).31P{1H} (162 MHz, C6D6, 25 ºC) δ 7.7 (s, 1P, Ph2P). 
MS (ESI) Expected: 545.1836, found: 545.1822 [M+H]+ (err [ppm] = 2.50). Elemental 
analysis C30H29N2O6P: calcd. C 66.17, H 5.37, N 5.14; found: C 65.89, H 5.25, N 5.07 %. IR 
(ATR) ν/cm-1 = 3161 (N-H), 1719 (PC=O), 1544 (C=O). 
 
Ph2PC(=O)N(4-BrC6H4)C(=O)NH(4-BrC6H4) (4d).  
White solid: 406 mg, 79%.1H NMR (400 MHz, C6D6, 25 ºC ) δ 
11.41 (s, 1H, NH), 7.58–7.47 (m, 4H, PPh2o), 7.30 (d, 3J(H,H) = 
9.0 Hz, 2H, PhBm), 7.13 (d, 3J(H,H) = 9.0 Hz, 2H, PhBo), 7.09–6.97 
(m, 6H, PPh2m+p), 6.92 (d, 3J(H,H) = 8.6 Hz, 2H, PhAm), 6.40 (dd, 
3J(H,H) = 8.6 Hz, 5J(H,P) = 1.5 Hz, 2H, PhAo). 13C{1H} (101 MHz, 
C6D6, 25 ºC) δ 185.0 (d, 1J(C,P) = 31 Hz, PC=O), 150.8 (C=O), 137.1 (PhBi), 135.1 (d, 
2J(C,P) = 21 Hz, PPh2o), 134.7 (d, 3J(C,P) = 4 Hz, PhAi), 134.6 (PhAp), 134.0 (PPh2i), 133.4 
(d, 4J(C,P) = 4 Hz, PhAo), 132.1 (PhBo), 131.3 (PhAm), 129.8 (PPh2p), 128.8 (d, 3J(C,P) = 8 
Hz, PPh2m), 121.3 (PhBm), 116.6 (PhBp). 31P{1H} (162 MHz, C6D6, 25 ºC) δ 8.8 (s, 1P, Ph2P).  
MS (ESI) Expected: 580.9642, found: 580.9624 [M+H]+ (err [ppm] = 3.20). IR (ATR) ν/cm-1 
= 3268 (N-H), 1717 (PC=O), 1594 (C=O). 
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Ph2PC(=O)N(nHx)C(=O)NH(nHx) (4e). 
Was prepared in situ by addition of Ph2PH (51 µL, 0.293 
mmol) and nHxNCO (85 µL, 0.586 mmol) to a solution of 1 
(10.0 mg, 5 mol%) in C6D6. After 16 h at r.t the solution was 
studied by NMR spectroscopy. Selected spectroscopic data: 
1H NMR (400 MHz, C6D6, 25 ºC) δ 9.22 (s, 1H, NH), 7.55–
7.45 (m, 4H, PPh2o), 7.07-6.99 (m, 6H, PPh2m+p), 4.03 (t, 2H, 
3J(H,H) = 4.6 Hz, CH21a), 3.25 (q, 2H, 3J(H,H) = 4.2 Hz, CH21b), 1.64 (m, 2H, CH22a), 1.34 
(br t, 3J(H,H) = 5.6 Hz, CH22b), 1.17–1.04 (m, 12H, CH23a,4a,5a + CH23a,4a,5a), 0.81 (m, 4H, 
CH36a+6b). 13C{1H} NMR (101 MHz, C6D6, 25 °C): δ 182.8 (d, 1J(C,P) = 25 Hz, PC=O), 154.4 
(CO), 135.0 (d, 2J(C,P) = 20 Hz, PPh2o), 133.4 (d, 1J(C,P) = 7 Hz, PPh2i), 46.2 (d, 4J(C,P) = 
19 Hz, CH21a), 40.6 (CH21b), 28.2 (CH22a+2b), 26.6 (CH2), 22.5 (CH2), 14.4(CH36a+6b). 31P{1H} 
(162 MHz, C6D6, 25 ºC) δ 8.4 (s, 1P, Ph2P). MS (ESI) Expected: 441.2665, found: 441.2677 
[M+H]+ (err [ppm] = 2.60) (7.9%).  
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NMR Spectra 
 
Figure S1. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 3a in C6D6. Spectroscopic data matched previous 
reported literature.3 
 
 
21 
 
Figure S2. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 3c in C6D6.  
 
Figure S3. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
complex of complex 3d in C6D6. Spectroscopic data matched previous reported literature.3 
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Figure S4. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 3f in C6D6. Spectroscopic data matched previous 
reported literature.3  
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Figure S5. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 3g in C6D6. 
 
Figure S6. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 3h in C6D6.  
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Figure S7. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 4a in C6D6. 
 
 
Figure S8. Selected region of the 1H, 31P{1H} (framed in blue) and 13C{1H} (framed in red) 
NMR spectra complex of complex 4b in C6D6.  
25 
 
 
Figure S9. Selected region of the 1H, 31P{1H} (framed in blue) and13C{1H} (framed in red) 
NMR spectra complex of complex 4c in C6D6. 
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Figure S10. Selected region of the 1H, 31P{1H} (framed in blue) and13C{1H} (framed in red) 
NMR spectra complex of complex 4d in C6D6.  
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NMR Reaction Monitoring 
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Figure S11. Conversion (%) vs. time (hour) for the hydrophosphination of PhNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C. 
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Figure S12. Conversion (%) vs. time (hour) for the hydrophosphination of PhNCO with 5 
mol% cat. of 2 in C6D6 at 25 °C.  
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Figure S13. Conversion (%) vs. time (hour) for the hydrophosphination of pTolNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C. Peaks for 3 and 4 overlapped in the 31P{1H} NMR spectra. 
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Figure S14. Conversion (%) vs. time (hour) for the hydrophosphination of pTolNCO with 5 
mol% cat. of 2 in C6D6 at 25 °C.   
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Figure S15. Conversion (%) vs. time (hour) for the hydrophosphination of 
3,5-(OMe)2C6H3NCO with 5 mol% cat. of 1 in C6D6 at 25 °C. 
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Figure S16. Conversion (%) vs. time (hour) for the hydrophosphination of 
3,5-(OMe)2C6H3NCO with 5 mol% cat. of 2 in C6D6 at 25 °C.  
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Figure S17. Conversion (%) vs. time (hour) for the hydrophosphination of nHxNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C. Reaction followed by 1H NMR. 
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Figure S18. Conversion (%) vs. time (hour) for the hydrophosphination of nHxNCO with 5 
mol% cat. of 2 in C6D6 at 25 °C. Reaction followed by 1H NMR.   
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Figure S19. Conversion (%) vs. time (hour) for the hydrophosphination of CyNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C. 
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Figure S20. Conversion (%) vs. time (hour) for the hydrophosphination of CyNCO with 5 
mol% cat. of 2 in C6D6 at 25 °C.  
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Figure S21. Conversion (%) vs. time (hour) for the hydrophosphination of iPrNCO with 5 
mol% cat. of 1 in C6D6 at 60 °C. 
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Figure S22. Conversion (%) vs. time (hour) for the hydrophosphination of iPrNCO with 5 
mol% cat. of 2 in C6D6 at 60 °C.  
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Figure S23. Conversion (%) vs. time (hour) for the hydrophosphination of CyNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C with a drop of mercury. 
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Figure S24. Conversion (%) vs. time (hour) for the hydrophosphination of CyNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C with CS2.  
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Figure S25. Conversion (%) vs. time (hour) for the hydrophosphination of CyNCO with 5 
mol% cat. of 1 in C6D6 at 25 °C with an excess of cumene. 
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X-ray Structure Analyses 
 
Figure S26. Molecular structure of 3a with anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(1)] have been omitted for clarity. 
 
 
Figure S27. Molecular structure of 3c with anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(1)] and minor disorder components of 
the molecule have been omitted for clarity.  
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Figure S28. Molecular structure of 3d with anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(1)] and minor disorder components of 
the molecule have been omitted for clarity 
 
 
 
Figure S29. Molecular structure of 3f anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(1)] have been omitted for clarity. 
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Figure S30. Molecular structure of 3g with anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(1)] have been omitted for clarity. 
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Figure S31. Molecular structure of 3h anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(1)] have been omitted for clarity.  
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Figure S32. Molecular structure of 4a with anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(2)] have been omitted for clarity. 
 
 
 
Figure S33. Molecular structure of 4b with anisotropic displacement parameters set at 50% 
probability. Hydrogen atoms [with the exception of H(2)] have been omitted for clarity.  
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Crystallographic Methods 
Under a flow of nitrogen, crystals suitable for analysis by X-ray diffraction were quickly 
removed from the crystallisation vessel and covered in YR-1800 perfluoropolyether oil. 
Crystals were mounted on a MiTeGen MicroMount™ and cooled rapidly in a cold stream of 
nitrogen using an Oxford Cryostreams open flow cryostat.4 Single crystal X-ray diffraction 
data were collected on Rikagu Oxford Diffraction SuperNova diffractometer (mirror-
monochromated Cu-Kα radiation source; λ = 1.54184 Å; ω scans), equipped with either an 
Atlas, AtlasS2 or TitanS2 detector. Cell parameters were refined from the observed positions 
of all strong reflections in each data set and absorption corrections were applied using a 
Gaussian numerical method with beam profile correction (CrysAlisPro).5 The structures were 
solved either by direct or iterative methods and all non-hydrogen atoms refined by full-matrix 
least-squares on all unique F2 values with anisotropic displacement parameters. Hydrogen 
atoms were refined with constrained geometries and riding thermal parameters with the 
exception of amide hydrogen atoms whose positions were refined freely. Programs used 
include CrysAlisPro5 (control of Supernova, data integration and absorption correction), 
SHELXL6 (structure refinement), SHELXS7 (structure solution), SHELXT8 (structure 
solution), OLEX29 (molecular graphics). Structure 3d was a 2-component twin. The 
orientations of the two twin components were determined in CryAlisPro,5 and integrated to 
provide a single component HKL file which was used for the initial solution, and a multi-
component HKL file which was used for the final refinement of the structure. CIF files were 
checked using checkCIF.10 CCDC-1529760-1529767 contain the supplementary data for 
3a,c,d,f-h and 4a,b. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Crystal data for PPh2C(=O)NH(Ph) (3a)  
C19H16NOP (M =305.30 g/mol): orthorhombic, space group Pbca (no. 61), a = 10.3671(4), 
b = 9.7004(3), c = 30.7223(11) Å, V = 3089.59(18) Å3, Z = 8, T = 120(2) K, μ(Cu-Kα) = 1.573 
mm-1, Dcalc = 1.313 g/cm3, 7371 reflections measured (10.294° ≤ 2Θ ≤ 148.912°), 3060 
unique (Rint = 0.0244, Rsigma = 0.0281) which were used in all calculations. The final R1 was 
0.0348 (I > 2σ(I)) and wR2 was 0.0916 (all data). 
 
  
42 
 
Crystal data for PPh2C(=O)NH(3,5-(OMe)2C6H3) (3c) 
C21H20NO3P (M = 365.35 g/mol): orthorhombic, space group Iba2 (no. 45), a = 37.803(3), 
b = 10.3736(7), c = 9.4895(7) Å, V = 3721.3(5) Å3, Z = 8, T = 120(2) K, μ(Cu-Kα) = 1.476 
mm-1, Dcalc = 1.304 g/cm3, 4993 reflections measured (8.84° ≤ 2Θ ≤ 149.442°), 2553 unique 
(Rint = 0.0440, Rsigma = 0.0483) which were used in all calculations. The final R1 was 0.0661 
(I > 2σ(I)) and wR2 was 0.1754 (all data). 
 
Crystal data for PPh2C(=O)NH(4-BrC6H4) (3d)  
C19H15NOPBr (M = 384.20 g/mol): monoclinic, space group P21/c (no. 14), a = 16.4956(7), 
b = 10.3340(5), c = 9.7346(4) Å, β = 94.043(4)°, V = 1655.28(13) Å3, Z = 4, T = 120(2) K, 
μ(Cu-Kα) = 4.319 mm-1, Dcalc = 1.542 g/cm3, 6619 reflections measured (10.108° ≤ 2Θ ≤ 
148.846°), 6619 unique (Rsigma = 0.0260) which were used in all calculations. The final R1 
was 0.0729 (I > 2σ(I)) and wR2 was 0.208 (all data). 
 
Crystal data for PPh2C(=O)NH(Cy) (3f) 
C19H22NOP (M = 311.34 g/mol): orthorhombic, space group Iba2 (no. 45), a = 34.1888(3), 
b = 10.64763(8), c = 9.49011(9) Å, V = 3454.68(5) Å3, Z = 8, T = 120(2) K, μ(Cu-Kα) = 1.408 
mm-1, Dcalc = 1.197 g/cm3, 37101 reflections measured (8.698° ≤ 2Θ ≤ 147.574°), 3273 
unique (Rint = 0.0426, Rsigma = 0.0151) which were used in all calculations. The final R1 was 
0.0360 (I > 2σ(I)) and wR2 was 0.0949 (all data). 
 
Crystal data for PPh2C(=O)NH(iPr) (3g) 
C16H18NOP (M = 271.28 g/mol): orthorhombic, space group Pbca (no. 61), a = 11.1668(2), 
b = 9.5381(2), c = 28.3885(5) Å, V = 3023.67(10) Å3, Z = 8, T = 120(2) K, μ(Cu-Kα) = 1.536 
mm-1, Dcalc = 1.192 g/cm3, 15166 reflections measured (10.078° ≤ 2Θ ≤ 147.404°), 3017 
unique (Rint = 0.0397, Rsigma = 0.0252) which were used in all calculations. The final R1 was 
0.0350 (I > 2σ(I)) and wR2 was 0.0963 (all data). 
 
Crystal data for PPh2C(=O)NH(tBu) (3h) 
C17H20NOP (M = 285.31 g/mol): triclinic, space group P-1 (no. 2), a = 10.1317(3), b = 
10.5022(4), c = 14.6490(6) Å, α = 87.932(3), β = 89.517(3), γ = 89.127(3)°, V = 
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1557.48(9) Å3, Z = 4, T = 120(2) K, μ(Cu-Kα) = 1.515 mm-1, Dcalc = 1.217 g/cm3, 11349 
reflections measured (8.426° ≤ 2Θ ≤ 147.656°), 6080 unique (Rint = 0.0347, Rsigma = 0.0435) 
which were used in all calculations. The final R1 was 0.0343 (I > 2σ(I)) and wR2 was 0.0917 
(all data). 
 
Crystal data for PPh2C(=O)N(Ph)C(=O)NH(Ph) (4a)  
C26H21N2O2P (M = 424.42 g/mol): orthorhombic, space group P212121 (no. 19), a = 
5.9842(2), b = 10.9578(5), c = 31.8272(12) Å, V = 2087.01(15) Å3, Z = 4, T = 120(2) K, 
μ(Cu-Kα) = 1.377 mm-1, Dcalc = 1.351 g/cm3, 5909 reflections measured (5.554° ≤ 2Θ ≤ 
147.524°), 3561 unique (Rint = 0.0515, Rsigma = 0.0652) which were used in all calculations. 
The final R1 was 0.0597 (I > 2σ(I)) and wR2 was 0.159  (all data). 
 
Crystal data for PPh2C(=O)N(pTol)C(=O)NH(pTol) (4b) 
C28H25N2O2P (M = 452.47 g/mol): monoclinic, space group C2/c (no. 15), a = 26.103(3), b = 
5.7961(5), c = 32.100(4) Å, β = 104.115(11)°, V = 4710.0(9) Å3, Z = 8, T = 119.97(12) K, 
μ(Cu-Kα) = 1.251 mm-1, Dcalc = 1.276 g/cm3, 27055 reflections measured (6.984° ≤ 2Θ ≤ 
151.008°), 4797 unique (Rint = 0.0917, Rsigma = 0.0497) which were used in all calculations. 
The final R1 was 0.0779 (I > 2σ(I)) and wR2 was 0.232 (all data). 
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